Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 24 citing articles:

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
Angela R. Branche, Nadine Rouphael, David Diemert, et al.
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2334-2346
Open Access | Times Cited: 33
Effectiveness of COVID-19 vaccination against COVID-19 specific and all-cause mortality in older Australians: a population based study
Bette Liu, Sandrine Stepien, Timothy Dobbins, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 40, pp. 100928-100928
Open Access | Times Cited: 20
Australia’s COVID-19 vaccine journey: progress and future perspectives
James A. Triccas, Megan Steain
Microbiology Australia (2024)
Open Access | Times Cited: 4
SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022
Lauren Bloomfield, Sera Ngeh, Gemma Cadby, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 6
Open Access | Times Cited: 11
Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection
Bette Liu, Sandrine Stepien, Jiahui Qian, et al.
Vaccine (2023) Vol. 41, Iss. 38, pp. 5587-5591
Open Access | Times Cited: 11
Understanding SARS-CoV-2 Delta and Omicron variant transmission and vaccine impact in schools and child-care settings in Australia: a population-based study
Archana Koirala, Noni Winkler, Helen Quinn, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 35, pp. 100736-100736
Open Access | Times Cited: 10
Effectiveness of a booster dose of COVID-19 vaccines during an outbreak of SARS-CoV-2 Omicron BA.2.2 in China: A case–control study
Xiaqing Zhang, Yao Wang, Cheng‐Yang Hu, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 10
The Psychology of COVID-19 Booster Hesitancy, Acceptance and Resistance in Australia
Sabina Kleitman, Dayna J. Fullerton, Marvin K. H. Law, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 907-907
Open Access | Times Cited: 9
Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort
Ida Laake, Siri N. Skodvin, Kristine Blix, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 11, pp. 1924-1933
Open Access | Times Cited: 15
Comparing surveyed adults with long COVID and those with just a positive test helps put COVID into perspective
Mary L. Adams, Joseph Grandpre
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Efficacy and effectiveness of COVID-19 vaccines in Africa: A systematic review
Tajudeen Raji, Mosoka Papa Fallah, Nebiyu Dereje, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0306309-e0306309
Open Access | Times Cited: 1
Post-vaccination, post-infection and hybrid immunity against severe cases of COVID-19 and long COVID after infection with SARS-CoV-2 Omicron subvariants, Czechia, December 2021 to August 2023
Martin Šmíd, Tamara Barusová, Jiří Jarkovský, et al.
Eurosurveillance (2024) Vol. 29, Iss. 35
Open Access | Times Cited: 1
Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial
Angela R. Branche, Nadine Rouphael, David Diemert, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 4
Beyond adaptive immunity: induction of trained immunity by COVID-19 adenoviral vaccines
Mihai G. Netea, Leo A. B. Joosten
Journal of Clinical Investigation (2023) Vol. 133, Iss. 2
Open Access | Times Cited: 3
Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium
Marjan Meurisse, Lucy Catteau, Joris Adriaan Frank van Loenhout, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 378-378
Open Access | Times Cited: 3
The relative effectiveness of three and four doses of COVID-19 vaccine in Victoria, Australia: A data linkage study
Jose T. Canevari, Allen C. Cheng, Logan Wu, et al.
Vaccine (2023) Vol. 42, Iss. 1, pp. 53-58
Open Access | Times Cited: 3
Discretion in decision to receive COVID-19 vaccines and associated socio-economic inequalities in rates of uptake: a whole-of-population data linkage study from Australia
Jennifer Welsh, Nicholas Biddle, Danielle Butler, et al.
Public Health (2023) Vol. 224, pp. 82-89
Open Access | Times Cited: 2
Methodology of comparative studies on the relative effectiveness of COVID-19 vaccines: a systematic review
Erdenetuya Bolormaa, Ji Ae Shim, Young-Sook Choi, et al.
Osong Public Health and Research Perspectives (2024) Vol. 15, Iss. 5, pp. 395-408
Open Access
Analysis of the epidemic situation of the COVID-19 coronavirus infection in Ukraine
Alla Podavalenko, Нина Григорьевна Малыш, В. І. Задорожна, et al.
Folia Medica Cracoviensia (2023)
Open Access | Times Cited: 1
Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection
Bette Liu, Sandrine Stepien, Jiahui Qian, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Understanding and Improving Vaccine Effectiveness Estimates in the Age of Widespread Background Immunity: A Step Toward Improved Science Communication
Edward Nirenberg, Eli N. Perencevich
Clinical Infectious Diseases (2023) Vol. 76, Iss. 9, pp. 1535-1538
Open Access
Identifying a more severe emergent COVID-19 variant using Emergency Departments’ routinely collected clinical measures
Adelaide Nyinawingeri, Michael Staff
Communicable Diseases Intelligence (2023) Vol. 46
Open Access
Postvaccination breakthrough SARS-CoV-2 infections among adults in Malaysia and attitudes towards future vaccination
Praneetha Kumar Nair, Kai Ern Koh, Christine Yvonne Bede, et al.
Asian Pacific Journal of Tropical Medicine (2023) Vol. 16, Iss. 7, pp. 296-304
Open Access
Effectiveness of COVID-19 Vaccine Doses in Children: Case of Lake Region Economic Bloc-Kenya
Shem Otoi Sam, Naomy Onyuka, Michael Audi, et al.
Open Journal of Modelling and Simulation (2023) Vol. 11, Iss. 03, pp. 88-97
Open Access
Page 1

Scroll to top